General MedicationsORALStandard
LOGILIA
ULIPRISTAL ACETATE
Standard Dose
30MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview LOGILIA is listed in Drugs@FDA under application 207952 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ULIPRISTAL ACETATE Form and strength TABLET;ORAL - 30MG Sponsor TEVA PHARMS USA Submission history Latest submission status date: 2017-02-13 00:00:00.
Structured Monograph
Clinical summary
Approval overview LOGILIA is listed in Drugs@FDA under application 207952 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ULIPRISTAL ACETATE Form and strength TABLET;ORAL - 30MG Sponsor TEVA PHARMS USA Submission history Latest submission status date: 2017-02-13 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.